中国大型肿瘤性骨软化症患者队列中的甲状旁腺功能亢进症
本回顾性研究纳入202例中国肿瘤性骨软化症(TIO)患者,发现甲状旁腺功能亢进症(HPT)发生率为45.1%(91/202),其中继发性HPT 84例(41.6%)、三发性HPT 7例(3.5%)。多因素logistic回归显示长病程和磷酸盐补充与HPT独立相关,且磷酸盐累积剂量与PTH水平呈剂量-反应关系。
要点
- TIO患者中HPT常见,继发性HPT占41.6%,三发性HPT占3.5%。
- 继发性HPT患者病程更长、磷酸盐和骨化三醇补充率更高、血钙更低。
- 长病程和磷酸盐补充是TIO患者发生HPT的独立相关因素。
核心结论
- HPT在TIO患者中常见,为避免HPT发生,及时诊断和肿瘤切除是必要的,术前不建议过度补充磷酸盐。
研究设计与样本
- 回顾性研究,纳入202例中国TIO患者,旨在明确HPT的患病率、临床特征和危险因素。
主要发现
- 91例(45.1%)发生HPT,其中继发性HPT 84例(41.6%),三发性HPT 7例(3.5%)。
- 所有三发性HPT患者均行甲状旁腺切除术,仅1例复发。
- 与无HPT患者相比,继发性HPT患者病程更长、磷酸盐和骨化三醇补充率更高、血钙更低、尿钙排泄更低、尿磷排泄更高。
- 与继发性HPT患者相比,三发性HPT患者病程更长、磷酸盐和骨化三醇补充率更高。
- TIO患者中PTH水平与完整FGF23和1,25-二羟维生素D水平正相关,与25-羟维生素D水平无相关性。
关键数值与推荐
- 多因素logistic回归分析显示,长病程和磷酸盐补充与TIO患者发生HPT独立相关。
- 进一步的logistic回归分析和限制性立方样条模型揭示磷酸盐补充累积剂量与PTH水平之间存在剂量-反应关系。
临床怎么用
- 作者认为,为避免TIO患者发生HPT,及时诊断和肿瘤切除是必要的,术前不建议过度补充磷酸盐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by excessive production of fibroblast growth factor 23 (FGF23) by a tumor. Hyperparathyroidism (HPT) including secondary HPT (SHPT) and tertiary HPT (THPT) in TIO patients, which is believed to be associated with phosphate supplementation, has not been well documented. OBJECTIVES: To clarify the prevalence, clinical characteristics, and risk factors for HPT in a large cohort of Chinese patients with TIO in our hospital. DESIGN, SETTING, AND PARTICIPANTS: This retrospective study enrolled 202 patients with TIO. MAIN OUTCOME MEASUREMENTS: Occurrence of HPT in patients with TIO. RESULTS: HPT was observed in 91 patients (91/202, 45.1%): 84 patients (41.6%) with SHPT and 7 patients (3.5%) with THPT. All patients with THPT underwent parathyroidectomy and only 1 patient experienced recurrence. Compared with patients without HPT, patients with SHPT had longer disease duration, higher rate of phosphate and calcitriol supplementation, lower serum calcium, lower urine calcium excretion, and higher urine phosphate excretion. Compared with patients with SHPT, patients with THPT had even longer disease duration and a higher rate of phosphate and calcitriol supplementation. PTH levels showed positive correlation with intact FGF23 and 1,25-dihydroxyvitamin D levels, but not 25-hydroxy vitamin D level in patients with TIO. Multivariate logistic regression analysis showed that long disease duration and phosphate supplementation were independently associated with occurrence of HPT in patients with TIO. Further logistic regression analysis and restricted cubic spline model revealed dose-response relationship between cumulative dose of phosphate supplementation and PTH levels. CONCLUSIONS: HPT is common in patients with TIO. To avoid the occurrence of HPT in patients with TIO, timely diagnosis and tumor resection is necessary and an excessive dose of phosphate supplementation is not suggested before surgery.
引用
- Ni X, Liu W, Zhang D, et al. Hyperparathyroidism in a Large Cohort of Chinese Patients With Tumor-induced Osteomalacia. J Clin Endocrinol Metab. 2023. PMID: 36334263. doi:10.1210/clinem/dgac650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。